Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Shoulson

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Where do we stand on neuroprotection? Where do we go from here?I Shoulson
Archivos De Neurobiologia|November 1, 1991
[Therapeutic strategies in Parkinson's disease]I Shoulson
Neurology|August 1, 1975
Caffeine and the antiparkinsonian response to levodopa or piribedilI Shoulson, T Chase
Clinical Neuropharmacology|December 1, 1982
Up and down regulation: clinical significance of nervous system receptor-drug interactionsR Kurlan, I Shoulson
Advances in Neurology|January 1, 1988
Differential diagnosis of facial choreaR Kurlan, I Shoulson
Annals of Neurology|April 1, 1983
Familial paroxysmal dystonic choreoathetosis and response to alternate-day oxazepam therapyR Kurlan, I Shoulson
Neurology|January 1, 1979
Huntington disease: clinical care and evaluationI Shoulson, S Fahn
Advances in Neurology|January 1, 1975
Dopaminergic mechanisms in patients with extrapyramidal diseaseT N Chase, I Shoulson
Archives of Neurology|May 18, 1999
Neurotherapeutics, evidence-based neurology, and clinical equipoiseI Shoulson, R N Rosenberg
JAMA|February 26, 1973
Albright syndrome and leukemiaI Shoulson, P F Griner
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Where do we stand on neuroprotection? Where do we go from here?I Shoulson
Archivos De Neurobiologia|November 1, 1991
[Therapeutic strategies in Parkinson's disease]I Shoulson
Neurology|August 1, 1975
Caffeine and the antiparkinsonian response to levodopa or piribedilI Shoulson, T Chase
Clinical Neuropharmacology|December 1, 1982
Up and down regulation: clinical significance of nervous system receptor-drug interactionsR Kurlan, I Shoulson
Advances in Neurology|January 1, 1988
Differential diagnosis of facial choreaR Kurlan, I Shoulson
Annals of Neurology|April 1, 1983
Familial paroxysmal dystonic choreoathetosis and response to alternate-day oxazepam therapyR Kurlan, I Shoulson
Neurology|January 1, 1979
Huntington disease: clinical care and evaluationI Shoulson, S Fahn
Advances in Neurology|January 1, 1975
Dopaminergic mechanisms in patients with extrapyramidal diseaseT N Chase, I Shoulson
Archives of Neurology|May 18, 1999
Neurotherapeutics, evidence-based neurology, and clinical equipoiseI Shoulson, R N Rosenberg
JAMA|February 26, 1973
Albright syndrome and leukemiaI Shoulson, P F Griner
Pageof 11